Documentos relacionados

1. The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial.
2. A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States.
3. Effects of Low-Dose Tadalafil in a Patient with Biventricular Heart Failure: A Case Report.
4. Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements.
5. Phosphodiesterase Type-5 Inhibitor Prescription Patterns in the United States Among Men With Erectile Dysfunction: An Update.
6. Diketopiperazine-Based, Flexible Tadalafil Analogues: Synthesis, Crystal Structures and Biological Activity Profile.
7. Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.
8. Assessment of the intracavernosal injection platelet-rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non-responding to on-demand oral PDE5 inhibitors.
9. Are We Overstating the Risk of Priapism With Oral Phosphodiesterase Type 5 Inhibitors?
10. [Combination of 1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study].